Build awareness on Mounjaro - the first GIP & GLP-1 receptor agonist through an engaging discussion with investigators covering:
• MoA
• Phase Ill SURPASS trial program.
Objectives
.
This Course For :
Physician
( Endocrinology & Metabolism )
Resident / Fellow
( Endocrinology & Metabolism )
Speaker
Dr. Bruno Halpern
Chief-Director, Obesity Centre, Hospital 9 de Julho, Sao Paulo
Prof. Dr. Juris J. Meler
Researcher, Diabetes Center Bochum-Hattingen,
St. Josef Hospital, Bochum
Dr. Santiago Tote
Consultant, Dep. of Endocrinology, Uni. Hospital Son Espases, Ass. Professor University Illes Balears
Note : This content is sponsored and approved by Eli Lilly and company (Lilly). This content is intellectual property of Lilly and its reproduction needs Lilly prior permission.